Pantep Angchaisuksiri

About Pantep Angchaisuksiri

Pantep Angchaisuksiri, With an exceptional h-index of 39 and a recent h-index of 32 (since 2020), a distinguished researcher at Mahidol University, specializes in the field of Hematology, thrombosis, hemostasis.

His recent articles reflect a diverse array of research interests and contributions to the field:

Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: A global survey

Haemophilia care in Asia: Learning from clinical practice in some Asian countries

Venous thromboembolism prophylaxis in Asian patients with severe COVID-19: A prospective cohort study

Long-Term FVIII Expression with Reduced Bleeding Following Gene Transfer for Hemophilia A: Follow-up on the Dirloctocogene Samoparvovec Phase I/II Trial

Site-directed mutagenesis of tissue factor pathway inhibitor–binding exosite D60A on factor VII results in a new factor VII variant with lower coagulant activity

Rhythm versus rate control in patients with newly diagnosed atrial fibrillation–Observations from the GARFIELD-AF registry

The Effect of Concizumab Prophylaxis on Target Joints, Resolution and Joint Bleeds in Patients With Hemophilia A or B With or Without Inhibitors in Phase 3 Clinical Trials

OC 59.1 Concizumab Prophylaxis in Patients with Haemophilia A or B without Inhibitors: Efficacy and Safety Results from the Primary Analysis of the Phase 3 Explorer8 Study

Pantep Angchaisuksiri Information

University

Position

Professor of Medicine

Citations(all)

7375

Citations(since 2020)

4942

Cited By

3975

hIndex(all)

39

hIndex(since 2020)

32

i10Index(all)

80

i10Index(since 2020)

61

Email

University Profile Page

Google Scholar

Pantep Angchaisuksiri Skills & Research Interests

Hematology

thrombosis

hemostasis

Top articles of Pantep Angchaisuksiri

Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: A global survey

2024/4/4

Haemophilia care in Asia: Learning from clinical practice in some Asian countries

2024/3/24

Pantep Angchaisuksiri
Pantep Angchaisuksiri

H-Index: 24

Pol Chewcharat
Pol Chewcharat

H-Index: 2

Venous thromboembolism prophylaxis in Asian patients with severe COVID-19: A prospective cohort study

Thrombosis Update

2024/2/23

Pantep Angchaisuksiri
Pantep Angchaisuksiri

H-Index: 24

Long-Term FVIII Expression with Reduced Bleeding Following Gene Transfer for Hemophilia A: Follow-up on the Dirloctocogene Samoparvovec Phase I/II Trial

Hämostaseologie

2024/2

Site-directed mutagenesis of tissue factor pathway inhibitor–binding exosite D60A on factor VII results in a new factor VII variant with lower coagulant activity

Research and Practice in Thrombosis and Haemostasis

2024/1/1

Pantep Angchaisuksiri
Pantep Angchaisuksiri

H-Index: 24

Pansakorn Tanratana
Pansakorn Tanratana

H-Index: 6

Rhythm versus rate control in patients with newly diagnosed atrial fibrillation–Observations from the GARFIELD-AF registry

IJC Heart & Vasculature

2023/12/1

Dan Atar
Dan Atar

H-Index: 54

Shinya Goto
Shinya Goto

H-Index: 51

Pantep Angchaisuksiri
Pantep Angchaisuksiri

H-Index: 24

The Effect of Concizumab Prophylaxis on Target Joints, Resolution and Joint Bleeds in Patients With Hemophilia A or B With or Without Inhibitors in Phase 3 Clinical Trials

Blood

2023/11/28

Pantep Angchaisuksiri
Pantep Angchaisuksiri

H-Index: 24

OC 59.1 Concizumab Prophylaxis in Patients with Haemophilia A or B without Inhibitors: Efficacy and Safety Results from the Primary Analysis of the Phase 3 Explorer8 Study

Research and Practice in Thrombosis and Haemostasis

2023/10/1

OC 59.3 Pooled Safety Results from the Multidose Explorer Studies of Concizumab in Patients with Haemophilia

Research and Practice in Thrombosis and Haemostasis

2023/10/1

Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, the Middle East, and Turkey: final analysis of CITE

Blood Advances

2023/9/12

Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais

Thrombosis Journal

2023/9/6

Angsana Phuphuakrat
Angsana Phuphuakrat

H-Index: 8

Pantep Angchaisuksiri
Pantep Angchaisuksiri

H-Index: 24

Phase 3 trial of concizumab in hemophilia with inhibitors

New England Journal of Medicine

2023/8/31

Amy Shapiro
Amy Shapiro

H-Index: 11

Pantep Angchaisuksiri
Pantep Angchaisuksiri

H-Index: 24

Huyen Tran
Huyen Tran

H-Index: 24

Practices and challenges for hemophilia management under resource constraints in Thailand

Orphanet Journal of Rare Diseases

2023/5/10

Pantep Angchaisuksiri
Pantep Angchaisuksiri

H-Index: 24

Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH)

Blood research

2023/3/3

National strategic advocacy to manage patients with inherited bleeding disorders in low and lower-middle income countries

2023/12/2

Pantep Angchaisuksiri
Pantep Angchaisuksiri

H-Index: 24

Ponlapat Rojnuckarin
Ponlapat Rojnuckarin

H-Index: 12

Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke

Open Heart

2023/12/1

Shinya Goto
Shinya Goto

H-Index: 51

Pantep Angchaisuksiri
Pantep Angchaisuksiri

H-Index: 24

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic …

Blood advances

2022/9/13

Good recovery of immunization stress-related responses presenting as a cluster of stroke-like events following CoronaVac and ChAdOx1 vaccinations

Plos one

2022/8/25

Pantep Angchaisuksiri
Pantep Angchaisuksiri

H-Index: 24

Sasisopin Kiertiburanakul
Sasisopin Kiertiburanakul

H-Index: 23

See List of Professors in Pantep Angchaisuksiri University(Mahidol University)